Department of Cell Biology & Biochemistry, Texas Tech University Health Sciences Center, Lubbock, Texas, United States of America.
Department of Cell Physiology & Molecular Biophysics, Texas Tech University Health Sciences Center, Lubbock, Texas, United States of America.
PLoS One. 2021 May 19;16(5):e0251132. doi: 10.1371/journal.pone.0251132. eCollection 2021.
Methylation of the HLTF gene in colorectal cancer (CRC) cells occurs more frequently in men than women. Progressive epigenetic silencing of HLTF in tumor cells is accompanied by negligible expression in the tumor microenvironment (TME). Cell line-derived xenografts (CDX) were established in control (Hltf+/+) and Hltf-deleted male Rag2-/-IL2rg-/- mice by direct orthotopic cell microinjection (OCMI) of HLTF+/+HCT116 Red-FLuc cells into the submucosa of the cecum. Combinatorial induction of IL6 and S100A8/A9 in the Hltf-deleted TME with ICAM-1 and IL8 in the primary tumor activated a positive feedback loop. The proinflammatory niche produced a major shift in CDX metastasis to peritoneal dissemination compared to controls. Inducible nitric oxide (iNOS) gene expression and transactivation of the iNOS-S100A8/A9 signaling complex in Hltf-deleted TME reprogrammed the human S-nitroso-proteome. POTEE, TRIM52 and UN45B were S-nitrosylated on the conserved I/L-X-C-X2-D/E motif indicative of iNOS-S100A8/A9-mediated S-nitrosylation. 2D-DIGE and protein identification by MALDI-TOF/TOF mass spectrometry authenticated S-nitrosylation of 53 individual cysteines in half-site motifs (I/L-X-C or C-X-X-D/E) in CDX tumors. POTEE in CDX tumors is both a general S-nitrosylation target and an iNOS-S100A8/A9 site-specific (Cys638) target in the Hltf-deleted TME. REL is an example of convergence of transcriptomic-S-nitroso-proteomic signaling. The gene is transcriptionally activated in CDX tumors with an Hltf-deleted TME, and REL-SNO (Cys143) was found in primary CDX tumors and all metastatic sites. Primary CDX tumors from Hltf-deleted TME shared 60% of their S-nitroso-proteome with all metastatic sites. Forty percent of SNO-proteins from primary CDX tumors were variably expressed at metastatic sites. Global S-nitrosylation of proteins in pathways related to cytoskeleton and motility was strongly implicated in the metastatic dissemination of CDX tumors. Hltf-deletion from the TME played a major role in the pathogenesis of inflammation and linked protein S-nitrosylation in primary CDX tumors with spatiotemporal continuity in metastatic progression when the tumor cells expressed HLTF.
结直肠癌(CRC)细胞中的 HLTF 基因甲基化在男性中比女性更常见。肿瘤细胞中 HLTF 的进行性表观遗传沉默伴随着肿瘤微环境(TME)中可忽略不计的表达。通过将 HLTF+/+HCT116 Red-FLuc 细胞直接原位细胞微注射(OCMI)到盲肠的黏膜下层,在对照(Hltf+/+)和 Hltf 缺失的 Rag2-/-IL2rg-/- 小鼠中建立了源自细胞系的异种移植物(CDX)。在 Hltf 缺失的 TME 中组合诱导 IL6 和 S100A8/A9,以及在原发性肿瘤中诱导 ICAM-1 和 IL8,激活了正反馈回路。炎症前生态位导致 CDX 转移到腹膜扩散的主要转变与对照组相比。诱导型一氧化氮合酶(iNOS)基因表达和 iNOS-S100A8/A9 信号复合物的反式激活使 Hltf 缺失的 TME 中的人类 S-亚硝酰化蛋白质组发生重编程。POTEE、TRIM52 和 UN45B 在保守的 I/L-X-C-X2-D/E 基序上发生 S-亚硝基化,表明 iNOS-S100A8/A9 介导的 S-亚硝基化。2D-DIGE 和 MALDI-TOF/TOF 质谱分析鉴定的蛋白质鉴定通过 MALDI-TOF/TOF 质谱鉴定了 CDX 肿瘤中半位点(I/L-X-C 或 C-X-X-D/E)中 53 个半胱氨酸的 S-亚硝基化。在 Hltf 缺失的 TME 中,POTEE 既是一般 S-亚硝酰化靶标,也是 iNOS-S100A8/A9 特异性(Cys638)靶标。REL 是转录组学-S-亚硝酰化蛋白质组学信号汇聚的一个例子。该基因在具有 Hltf 缺失的 TME 的 CDX 肿瘤中被转录激活,并且在原发性 CDX 肿瘤和所有转移性部位均发现了 REL-SNO(Cys143)。源自 Hltf 缺失 TME 的原发性 CDX 肿瘤与所有转移性部位共享其 60%的 S-亚硝酰化蛋白质组。原发性 CDX 肿瘤中有 40%的 SNO 蛋白质在转移部位表达不同。与细胞骨架和运动相关的途径中的蛋白质的全局 S-亚硝化强烈暗示了 CDX 肿瘤转移的传播。TME 中 HLTF 的缺失在炎症发病机制中起主要作用,并将原发性 CDX 肿瘤中的蛋白质 S-亚硝酰化与肿瘤细胞表达 HLTF 时转移性进展的时空连续性联系起来。